Nationally, about 15 million adults have used injectable medicines for weight loss, according to the Gallup National Health and Well-Being Index .As usage increases, the effect is measurable.About 10 million Americans believe they have benefited from the injections, Gallups survey shows

First, the Hims advertisement violates your Guidelines for Health Related Product Advertising. According to the Guidelines, [p]rescription drug advertising must adequately reflect FDA guidelines for prescription drug commercials. Advertisements must also be accurate and not misleading, contain all material facts, communicate clearly that the product is available by prescription only, and instruct viewers to consult their physicians regarding the product. They must also disclose the most significant risks that appear in the labeling and contain a brief summary of all necessary information related to side effects and contraindications. Hims advertisement does not comply with any of these requirements, despite being specifically intended to market Hims prescription drug products including compounded, unapproved semaglutide

Both medications have their roles in obesity management, and the choice between the two will often fall on individual patient needs, preferences, medical history, and a healthcare providers recommendation
"My heart goes out to all the friends and family and collaborators lucky enough to be in his orbit
1% AHK-Cu (Copper Tripeptide-3) 1% Acetyl Tetrapeptide-3 Synthetic variant of GHK-Cu Research focused on hair follicles 30-second daily routine Not sure which